BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

MARIC HEALTHCARE, LLC — Lobbying — Receipts Report

LD-2 disclosure · 3rd Quarter - Report

MARIC HEALTHCARE, LLC

via HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP)

3rd Quarter (July 1 - Sep 30) · 2024Posted Oct 16, 2024Filing document ↗LDA record ↗

Income$30Kfee reported

Client

Name: MARIC HEALTHCARE, LLC
Description: Opioid addiction treatment
Location: Texas · United States of America

Registrant

Firm: HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP)
Description: Law Firm
Location: WASHINGTON, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Promoting safe and effective treatment for opioid dependence.
LobbyistsNORM COLEMAN · CHASE KROLL
Covered position (NORM COLEMAN): U.S. Senator (2003-2009)
Covered position (CHASE KROLL): Legislative Assistant, Congresswoman Michele Bachmann (2010 - 2013)
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.